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Abstract Non-alcoholic fatty liver (NAFL) is the most
common liver disorder in western society. Various fac-
tors may play a role in determining hepatic fat content,
such as delivery of lipids to the liver, de novo lipogen-
esis, hepatic lipid oxidation, secretion of intrahepatic
lipids to the circulation or a combination of these. If
delivery of lipids to the liver outweighs the sum of
hepatic lipid oxidation and secretion, the intrahepatic
lipid (IHL) content starts to increase and NAFL may
develop. NAFL is closely related to obesity and insulin
resistance and a fatty liver increases the vulnerability to
type 2 diabetes development. Exercise training is a cor-
nerstone in the treatment and prevention of type 2 dia-
betes. There is a large body of literature describing the
beneficial metabolic consequences of exercise training
on skeletal muscle metabolism. Recent studies have
started to investigate the effects of exercise training on
liver metabolism but data is still limited. Here, first, we
briefly discuss the routes by which IHL content is mod-
ulated. Second, we review whether and how these con-
tributing routes might be modulated by long-term exer-
cise training. Third, we focus on the effects of acute
exercise on IHL metabolism, since exercise also might
affect hepatic metabolism in the physically active state.
This will give insight into whether the effect of exercise
training on IHL could be explained by the accumulated
effect of acute bouts of exercise, or whether adaptations
might occur only after long-term exercise training. The
primary focus of this review will be on observations
made in humans. Where human data is missing, data
obtained from well-accepted animal models will be
used.
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TAG Triacylglycerol
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The prevalence of obesity has reached pandemic propor-
tions [1]. Environmental factors such as consumption of
high-energy diets and low levels of physical activity are
likely to be underlying factors. Associated with obesity is
the excessive storage of lipids in skeletal muscle, heart
and liver, known as so-called ‘ectopic’ fat accumulation.
In liver, this is diagnosed as non-alcoholic fatty liver
(NAFL) if the fat accumulation occurs in the absence of
high alcohol consumption. In obese people, the prevalence
of NAFL may be as high as 50–70% [2, 3]. In a subset
of patients, NAFL may develop into non-alcoholic
steatohepatitis (NASH), cirrhosis or liver carcinoma [4].
Although NAFL is thought to be essentially benign and
to be fully reversible, NAFL strongly correlates with he-
patic and whole-body insulin resistance [2]. Insulin resis-
tance is the earliest hallmark in the development of type 2
diabetes and the prevalence of NAFL in type 2 diabetes is
estimated to be as high as 70% [2, 5]. Hepatic lipid ac-
cumulation can occur because of changes in the following:
(1) NEFA plasma concentrations; (2) lipids originating
from a meal; (3) de novo lipogenesis (DNL); (4) hepatic
export of VLDLs or (5) hepatic fat oxidation (Fig. 1).
These routes are briefly described below.
Conditions in which IHL accumulates
• Increased hepatic NEFA uptake due to higher fasting and/
or postprandial plasma NEFA concentrations
• Low partition of fatty acids to skeletal muscle (low chy-
lomicron clearance by muscle and low NEFA uptake)
• Elevated DNL; activated by elevated plasma glucose and
insulin concentrations
• Limited capacity to increase hepatic VLDL–TAG secre-
tion and hepatic mitochondrial oxidation
NEFA Hepatic NEFA uptake is not strictly regulated [6].
Thus, higher plasma NEFA concentrations (predominantly
originating from elevated adipose tissue lipolysis) directly re-
late to a higher hepatic NEFA influx, contributing to higher
hepatic triacylglycerol (TAG) content [6, 7]. It has been shown
that obese people with high intrahepatic lipid (IHL) content
have a twofold higher rate of lipolysis than obese people with
normal IHL content [8]. Using isotope tracers, Donnelly et al
[9] elegantly showed that during fasting conditions 60% of the
hepatic TAG content in patients with NAFL originated from
plasma NEFA. Thus, high fasting NEFA concentrations asso-
ciated with obesity might contribute to elevated IHL content
[10]. However, not all studies found an association between
fasting NEFA and IHL content [11–13], and some suggested
that elevated postprandial NEFA concentrations (due to a di-
minished insulin-inhibitory effect on adipose tissue lipolysis)
may be a more important factor contributing to ectopic lipid
accumulation [14, 15]. Suppression of plasma NEFAwas di-
minished during insulin infusion [11, 13] and during an
OGTT [10] in individuals with elevated IHL content, when
compared with obese [10, 13] and lean individuals [11] with
normal IHL content. In addition, when comparing patients
with NASH with healthy individuals, insulin-stimulated sup-
pression of lipolysis was significantly impaired, while fasting
lipolysis was comparable [16]. Thus, impaired insulin-
stimulated suppression of lipolysis may be an underlying fac-
tor in NAFL.
Lipids originating from a meal IHL content can directly
originate from dietary TAG, transported in chylomicron par-
ticles [17]. Release and uptake of TAG-containing chylomi-
crons occur via lipoprotein lipase (LPL), an enzyme located in
the endothelium of adipose tissue and skeletal muscle [17, 18].
The chylomicron remnants then penetrate the fenestrations in
the liver for receptor-mediated hepatic uptake [19].
Alternatively, dietary TAG can reach the liver via chylomi-
cron–TAG ‘spillover’ into the serum NEFA pool after incom-
plete lipolysis via LPL in the adipose tissue and skeletal mus-
cle [17, 19]. Various modulators of LPL, such as liver-
produced apolipoproteins and angiopoietin-like proteins, are
suggested to influence postprandial fat deposition in the liver
[18]. In individuals with NAFL, approximately 15% of the
hepatic TAG pool originates from dietary NEFAwhen a stan-
dard diet is consumed [9]. In isoenergetic conditions, the die-
tary fat concentration seems to be a determinant for the effect
on IHL content [20–22]. More specifically, consuming an
isoenergetic low-fat diet decreased IHL content [21, 22],
while consuming an isoenergetic high-fat diet increased IHL
content [21, 22]. Contrary to isoenergetic conditions, both
low- and high-fat hypoenergetic diets decreased IHL content,
often accompanied by a reduction in bodyweight [23]. In turn,
high-carbohydrate and high-fat hyperenergetic diets markedly
increased IHL content [23]. Carbohydrate overfeeding with
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fructose [24] or with glucose [24, 25] both significantly in-
creased IHL content in lean healthy men [24] and overweight/
obese men and women [25]. Thus, in energy imbalance, it
appears that the composition of the diet may be less important,
and that energy intake might be the main determinant for
changes in IHL content.
DNL DNL was initially thought to account for only a small
part of the hepatic TAG content in humans. However, insulin
is a strong stimulator of DNL [26] and thus in people with
hyperinsulinaemia (a common observation in NAFL) DNL
may be increased. Indeed, DNL was 5.3- and 3.7-fold higher
in hyperinsulinaemic obese individuals in comparison with
more insulin-sensitive lean and obese individuals, respective-
ly, after consumption of an isoenergetic high-fat, low-
carbohydrate diet for 5 days [27]. In patients with NAFL,
DNL contributed up to one-fourth of the hepatic TAG pool
measured after an overnight fast [9], and DNLwas significant-
ly higher in insulin-resistant individuals with NAFL than in
people with low IHL content [28]. Sevastianova et al [25]
found that DNL increased in proportion to the increase in
IHL content after 3 weeks of carbohydrate overfeeding, direct-
ly supporting a role for DNL in hepatic lipid accumulation.
Hepatic VLDL metabolism Rodents fed a methionine- and
choline-deficient (MCD) diet, thereby compromising the as-
sembly of VLDL, are commonly used to investigate NAFL
[29]. However, decreased VLDL production is generally not
thought to be an underlying factor in the development of
NAFL in humans and has only been described in relation to
rare apolipoprotein B-100 (ApoB-100) mutations [30].












































Fig. 1 Pathways involved in hepatic lipid metabolism and the effect of
exercise training on these pathways. Adipose tissue releases NEFA into
the plasma via the process of lipolysis. Elevated fasting and postprandial
plasma NEFA, originating from reduced inhibition of adipose tissue li-
polysis, are taken up at the hepatic site. Fat originating from a meal is
transported in chylomicrons. Adipose tissue and skeletal muscle take up
fatty acids originating from the chylomicron–TAG pool via the action of
LPL, while chylomicron remnants are taken up by the liver. However,
when dietary fat availability is very high, the released fatty acids end up in
the plasma NEFA pool via chylomicron–TAG ‘spillover’, and these
NEFA can be taken up by the liver. Furthermore, hyperinsulinaemia in-
creases hepatic glucose uptake, which activates DNL via sterol regulatory
element binding protein-1 (SREBP-1), FAS and ACC. To compensate for
the increased hepatic fat delivery and synthesis, hepatic TAG secretion
via VLDL and hepatic TAG mitochondrial oxidation are upregulated.
There is some evidence that exercise training decreases fasting and
postprandial NEFA, most likely via a decrease in adipose tissue lipolysis.
Moreover, exercise training increases uptake of NEFA by skeletal muscle
and as a consequence lowers hepatic NEFA availability. Higher activity of
LPL in skeletal muscle with exercise training increases the uptake of
chylomicron–TAG by skeletal muscle, again lowering flux to the liver.
In humans, exercise training lowers plasma insulin levels—a key player
for activation of DNL—suggesting that exercise training might lower
DNL activity, supported by animal data showing decreased ACC and
FAS activity. Furthermore, animal data show that a decrease in IHL con-
tent with exercise training happens in the presence of increased PGC-1α
and increased content of mitochondrial proteins used as markers of mito-
chondrial function (Cyt c, β-HAD and CS). Exercise training also lowers
hepatic VLDL–TAG secretion, possibly as a consequence of lower he-
patic TAG accumulation. Red circles represent inhibition of pathways
with exercise training; green circles represent stimulation of pathways
with exercise training
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IHL content has been observed repeatedly after an overnight
fast [28, 31–33] and during the postprandial phase [34, 35]. It
is, however, not yet completely clear how IHL content deter-
mines the VLDL–TAG secretion rate. While one study sug-
gested a linear relation between IHL content and VLDL–TAG
secretion [36], another study found a rise-to-plateau relation-
ship [31]. The latter study described a linear relationship be-
tween IHL content and VLDL–TAG secretion in individuals
with low IHL content, but not in those with NAFL.
Interestingly, the latter study found that, while VLDL–TAG
secretion was higher in people with NAFL, VLDL–ApoB-
100 production was unchanged [31]. Thus, the liver did not
increase VLDL particle production. Therefore, VLDL–TAG
secretion might reach its maximum when maximal TAG load
in the VLDL particles is reached, and hepatic TAG secretion
cannot further compensate for increasing hepatic lipid
delivery.
Hepatic mitochondrial metabolism Lipids are the preferred
hepatic energy source during the fasted state [37] and the
insulin-resistant fatty liver tends to activate hepatic oxidative
metabolism [13, 38]. Hepatic mitochondrial function is ele-
vated in individuals with NAFL, compared with obese con-
trols, and positively correlates with IHL content [8]. In liver
biopsies, Koliaki et al [39] found that mitochondrial respira-
tion was higher in obese individuals with and without NAFL
compared with lean control individuals, whereas mitochondri-
al content was comparable. Thus, NAFL develops in the pres-
ence of increased hepatic mitochondrial respiration, suggest-
ing that increased lipid oxidation (and VLDL–TAG secretion)
cannot fully compensate for the increased lipid delivery.
Interestingly, mRNA expression of key components for mito-
chondrial biogenesis was markedly reduced in individuals
with NAFL [39]. This could serve as a precedent for the de-
creased mitochondrial function observed in individuals with
NASH [39–42]. Indeed, in NASH patients, activity of all mi-
tochondrial respiratory chain complexes is diminished [42]
and hepatic mitochondrial respiration is significantly impaired
[39].
Effects of exercise training on IHL content
Liver fat metabolism Exercise training is a recognised cor-
nerstone in the treatment of obesity and its co-morbidities and
recent studies have shown that exercise training might also
have beneficial effects on IHL content [43–51]. Palmer and
Schaffner [52] made one of the earliest observations of a pos-
sible link between regular physical activity and NAFL. These
workers noted normalisation of alanine aminotransferase
(ALAT) plasma levels in overweight patients with NAFL
who had reduced their body weight by ≥10% via combined
dietary restriction and regular unstructured physical activity.
Since then, several studies have used proton magnetic reso-
nance spectroscopy (1H-MRS), the non-invasive gold stan-
dard method with which to measure IHL content, to measure
directly a reduction in IHL content with a combined weight
loss and exercise training programme [53]. Furthermore, in
the limited number of liver biopsy studies available, weight
loss and exercise training have been found to significantly
improve steatosis, lobular inflammation, ballooning injury
and NAFLD activity score in patients with NASH [53].
Recently, there has been interest in whether exercise training
per se, in the absence of weight loss, can reduce IHL content
as well. Until now, however, only a few longitudinal studies
that used 1H-MRS have investigated the direct effect of exer-
cise training on IHL content in humans [43–51, 54] (Table 1).
In older individuals, 12 weeks of supervised aerobic exer-
cise training for 1 h a day decreased IHL content significantly
compared with a non-exercising control group [44].
Consistently, in obese, sedentary adults, 16 weeks of aerobic
exercise training five times a week decreased IHL content by
10% in the absence of weight loss [50], and even 4 weeks of
aerobic exercise training positively affected IHL content in a
comparable group of individuals [46]. One study reported no
change in IHL content in overweight healthy men after
6 weeks of aerobic exercise training [54], but exercise was
limited to only three sessions of 20 min per week.
In addition, resistance exercise training for 8 weeks was
found to reduce IHL content by 13% in obese, sedentary
adults [45]. In the study of Bacchi et al [43], it was demon-
strated that aerobic training and resistance training decreased
IHL content to a similar extent (25–30% decrease from base-
line). Van der Heijden et al [51] showed that 12 weeks of
aerobic exercise training was also effective in lowering IHL
content in younger people, reporting a decrease in IHL content
from 8.9% to 5.6% in obese Hispanic adolescents.
Interestingly, at least during adolescence, the sex of an indi-
vidual seems to exert an effect. In the studies performed by
Lee et al [47, 48], adolescent boys showed decreased IHL
content after both aerobic and resistance exercise [47], while
girls only benefited from aerobic exercise training [48].
While the finding that exercise training reduces IHL con-
tent is very reproducible, the mechanisms by which exercise
training affects IHL content in humans are still unresolved.
The simplest view is that the increase in energy expenditure
due to physical activity simply induces a negative energy bal-
ance, which in turn may result in the mobilisation of hepatic
lipids as a substrate to fuel the energy deficit. Most exercise
training studies in which IHL content is decreased, however,
do not show significant changes in body mass [45, 46, 50] or
fat and fat free mass [44, 45, 50]. In fact, only Bacchi et al [43]
concluded that there was a significant reduction in BMI and
fat mass after exercise training compared with pre-exercise
conditions. In Bacchi’s 4 month supervised aerobic or resis-
tance exercise training programme, patients with type 2
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Table 1 Main outcomes of studies that measured the effect of exercise training on IHL (measured with 1H-MRS) in humans
Study/participant type Training protocol Length of
intervention
Intensity of exercise training
protocol
Effect on IHL Effect on other variables
van der Heijden et al (2010) [51]
Obese Hispanic adolescents Supervised AET
(n = 15)














No change =FM, =IS, =f-Ins, =f-Glu
Sullivan et al (2012) [50]
Obese NAFL patients Unsupervised AET
(n = 12)







Pugh et al (2014) [49]
Obese NAFL patients Supervised AET
(n = 13)
16 weeks 3×/week; 30 min at 30% of
HRR (weeks 1–4), 30 min
at 45% of HRR (weeks
5–8), 45 min at 45% of
HRR (weeks 9–12),
45 min at 60% of HRR
(weeks 13–16)
↓ ↓f-Glu, =IS, =BW, =VAT,
=f-Ins





3 months 3×/week; 40 min at 40%
of V
:
O2max (week 1), 60 min






↓BW, ↓FM, ↓VAT, =IS,






3 months 3×/week, 60 min, 10 exercises,
2× 8–12 repetitions; 60% of




↓BW, ↓FM, ↓VAT, ↑IS,
=f-Glu, =f-Ins, =2 h-Glu,
=2 h-Ins





3 months 3×/week; 40 min at 40%
of V
:
O2max (week 1), 60 min













3 months 3×/week, 60 min, 10 exercises,
2 × 8–12 repetitions; 60%





↓FM, =VAT, =IS, =f-Glu,
=f-Ins, =2 h-Glu, =2 h-Ins





4 weeks 3×/week, 30–45 min; 50%
(week 1), 60% (week 2),













8 weeks 3×/week, 8 exercises,
45–60 min; 50%
(weeks 1–6), 70%
(weeks 7 and 8) of 1RM
↓ ↑IS, ↓f-Glu, =BW, =FM,
=VAT, =f-NEFA, =f-Ins





12 weeks 3×/week, 60 min; 50%
(weeks 1–4), 60%
(weeks 5–8), 70%
(weeks 9–12) of Wmax
↓ (vs non-exercising
control)
↓BW, ↓f-Ins, ↓2 h-Glu,
↓2 h-Ins, =FM, =f-Glu
Bacchi et al (2013) [43]
Patients with type
2 diabetes and NAFL
Supervised AET
(n = 14)
4 months 3×/week, 60 min; 60–65%
HRR
↓ ↓FM, ↓VAT, ↑IS
Patients with type
2 diabetes and NAFL
Supervised RET
(n = 17)
4 months 3×/week, 9 exercises, 3 × 10
repetitions; 70–80% of 1RM
↓ ↓FM, ↓VAT, ↑IS









No change ↑IS, ↓f-NEFA, ↓IS-NEFA,
=BW, =FM
1RM, 1 repetition maximum; 2 h-Glu, 2 h glucose (OGTT); 2 h-Ins, 2 h insulin (OGTT); AET, aerobic exercise training programme; BW, body weight; f-
Glu, fasting glucose; f-Ins, fasting insulin; FM, fat mass; f-NEFA, fasting NEFA; HRR, heart rate reserve; IS, insulin sensitivity; IS-NEFA, insulin-stimulated
NEFA; RET, resistance exercise training programme; VAT, visceral adipose tissue; V
:
O2max, maximal oxygen uptake; Wmax, maximal performance
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diabetes and NAFL performed, three times a week, either
60 min of aerobic exercise training (60–65% of heart rate
reserve) or resistance exercise training focusing on nine major
muscle groups (70–80% of the 1 repetition maximum). Two
months before onset of the training programme participants
met with a nutritionist who provided encouragement to follow
a healthy diet, and this might have affected the observations.
Energy intake was measured by a 3 day food recall just before
and at the end of the exercise training intervention. After ex-
ercise training, energy intake decreased by 323.8 kJ/day
(77.4 kcal/day) in the aerobic training group and
384.5 kJ/day (91.9 kcal/day) in the resistance training group.
Therefore, the decrease in energy intake throughout the exer-
cise training programme might have been responsible for re-
duced BMI and fat mass, rather than the exercise training
programme itself.
As outlined above, hepatic lipid accumulation originates
due to changes in the delivery of lipids to the liver, changes
in hepatic lipid oxidation, changes in the secretion of IHLs to
the circulation or a combination of these factors. Since exer-
cise training has the potential to lower IHL content, it may
possibly do so by affecting one or more of the pathways in-
volved (see Fig. 1). Below, we review the current knowledge
on how exercise training affects the potential pathways in-
volved in hepatic lipid accumulation in humans, supported
by rodent data when no human data is available. By doing
so, we reveal gaps in the current knowledge and highlight
possibilities for future clinical research.
NEFA Endurance-trained individuals are characterised by low
fasting plasma NEFA concentrations [55], suggesting that reg-
ular exercise may have an effect on adipose tissue lipid NEFA
uptake and lipolysis. In line with this, a 6 month hypoenergetic
diet in combination with exercise resulted in decreased in vitro
basal adipocyte lipolysis in obese, postmenopausal women
[56]. Shojaee-Moradie and colleagues [54] reported a de-
creased basal glycerol rate of appearance (Ra) and palmitate
Ra (indicative of a lower rate of lipolysis) 72 h after a 6 week
exercise training programme in sedentary overweight men.
However, this was not accompanied by a reduction in IHL
content. Other studies did not find exercise training-induced
effects on adipose tissue lipolysis. For example, using adipose
microdialysis in 17 healthy elderly women, interstitial glycerol
levels were found not to be affected after 12 weeks of exercise
training [57]. Of note, studies that do report a decrease in adi-
pose tissue lipolysis often observed a parallel decreases in
(visceral) adipose tissue mass [54, 56], which can explain part
of the observed effect on plasma NEFA concentrations.
Exercise training-induced decreases in IHL content do not
necessarily occur in parallel with decreased plasma NEFA
concentrations in the fasted state. Several studies report a de-
crease in IHL content even though fasted plasma NEFA con-
centrations remained unchanged [45, 50]. Exercise training
also promotes whole-body insulin sensitivity and hence might
also promote insulin-stimulated suppression of adipose tissue
lipolysis [58]. We previously found that 12 weeks of com-
bined aerobic and resistance exercise training improved
insulin-mediated suppression of plasma NEFA in both indi-
viduals with type 2 diabetes and healthy controls matched for
BMI [59]. Similarly, in obese men, 12 weeks of dynamic
strength training did improve insulin-stimulated suppression
of plasma NEFA [60]. Nevertheless, absolute NEFA levels
during insulin infusion were comparable with pre-
intervention concentrations, and the effect was mainly due to
an increase in fasting plasma NEFA levels after the exercise
training protocol. In contrast, no change in insulin-stimulated
suppression of plasma NEFAwas observed after 12 weeks of
aerobic exercise training in people with impaired glucose tol-
erance [61, 62] and/or impaired fasting glucose [61]. In non-
obese sedentary women insulin-stimulated plasmaNEFA sup-
pression improved after 9 months of high intensity (80%
V
:
O2max), but not after moderate-intensity (65% V
:
O2max ), aer-
obic exercise training [63].
Next to the potential effect on adipose tissue lipolysis, exer-
cise training may also favour the clearance of plasma NEFA by
skeletal muscle. In this respect, it is well established that endur-
ance training improves whole-body fat oxidation [57, 64] and
that this is accompanied by higher plasma NEFA uptake in skel-
etal muscle. With exercise training, this increased capacity for
plasma NEFA uptake into the myocyte has been associated with
an upregulation ofmembrane-associated plasmaNEFA transport
proteins [65]. Using 14(R,S)-[18F]6-thia-heptadecanoic acid
(18F-FTHA, a plasma NEFA analogue that is transported across
the cellular membrane but is not further metabolised) during a
hyperinsulinaemic–euglycaemic clamp, it was found that, com-
pared with healthy sedentary individuals, athletes possessed a
higher plasma NEFA uptake in skeletal muscle, while hepatic
retention of plasmaNEFAwas 20% lower [66]. Moreover, using
the same plasma NEFA analogue in a monozygotic twin study,
hepatic plasma NEFA uptake was 33% lower in the more active
twin in comparison with the less active twin during a low-
intensity 90 min knee extension exercise [67].
Taken together, exercise training may lower IHL content
via effects on plasma NEFA. Whereas the effects on adipose
tissue lipolysis are less clear, exercise training does seem to
improve plasma NEFA uptake in skeletal muscle. This might
lower the plasma NEFA availability for the liver, lowering
hepatic plasma NEFA uptake and changing fatty acid
partitioning from liver to skeletal muscle.
Lipids originating from a meal In addition to its effects on
plasma NEFA levels, exercise training may also affect post-
prandial lipid metabolism. It is known that exercise training
lowers the serum TAG response to a fatty meal [68] and the
prevalence of postprandial hypertriacylglycerolaemia is
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significantly higher in sedentary people than in trained people
[69]. The reduction in postprandial hypertriacylglycerolaemia
associated with endurance exercise adaptations is due to a
decrease in chylomicron–TAG half-life [70]. The difference
in TAG half-life between athletes and sedentary men is most
probably due to a direct effect of exercise training on LPL-
mediated TAG removal to skeletal muscle [70].
Changes in the activity of LPL may play a major role in the
more favourable lipoprotein–lipid profile of physically active
individuals. Heparin is known to release LPL from its endothe-
lial binding sites into the circulating blood [71–73] and post-
heparin plasma LPL activity has been reported to be higher in
endurance-trained individuals than in inactive controls [72, 73].
Furthermore, post-heparin LPL activity was reported to be in-
creased after 20 weeks of endurance training in healthy, seden-
tary individuals [74]. The activity of LPL measured shortly
after heparin infusion represents that of LPL derived from skel-
etal muscle rather than from adipose tissue [71]. This suggests
that with exercise training postprandial TAGs are more likely to
be taken up by the skeletal muscle.
Hepatic lipase (HL) plays an important role in lipoprotein
remodelling [74], hydrolysing TAG and phospholipids from
chylomicrons, HDL, intermediate-density lipoprotein (IDL)
and LDL [75, 76], so that TAGs are taken up by the liver. It
was shown that post-heparin HL activity reduced significantly
after 20 weeks of endurance training [74], and this might
result in lower postprandial hepatic TAG uptake. Although
these indirect measurements suggest postprandial TAG
channelling towards skeletal muscle and away from the liver
with exercise training, the effect on postprandial hepatic fat
storage has not been investigated directly.
DNL The effect of exercise training on DNL has not been
investigated yet in humans. In animal models, however, a
limited number of studies have been performed. In OLETF
rats, exercise training reduced [77, 78] or prevented [79] he-
patic fat storage concomitant with decreases in levels of
acetyl-CoA carboxylase (ACC) and fatty acid synthase
(FAS), two key enzymes in hepatic de novo fatty acid synthe-
sis. Thus, at least in rats, there seems to be a link between
exercise training-induced effects on IHL content and DNL
activity. In all these animal studies, exercise training signifi-
cantly reduced fasting glucose and fasting insulin levels
[77–79]. Insulin is known to stimulate DNL from glucose
[26], and lowered plasma concentrations of insulin and glu-
cose may therefore blunt DNL. It is well documented that
plasma concentrations of insulin and glucose are lower in
endurance-trained individuals [80], due to improved whole-
body insulin sensitivity [55]. This holds true for the fasted
situation but even more so for the metabolic response to a
meal. In exercise training studies wherein IHL content was
lowered, significant decreases in fasting insulin [44, 48, 51],
fasting glucose [45, 49], 2 h (OGTT) glucose [44] and 2 h
(OGTT) insulin [44] upon exercise training have been report-
ed. Taken together, while there is no direct human data on
DNL activity, the observation of lower glucose and/or insulin
levels in humans is in line with the observations made in
animal models. Direct measurement of DNL activity before
and after exercise training could bring further mechanistic
understanding of the IHL content-lowering effect of exercise
training in humans.
Hepatic VLDL metabolism Although VLDL metabolism is
generally not thought to be an underlying factor in the devel-
opment of NAFL in humans, exercise training could still influ-
ence IHL content by modifying VLDL metabolism. As yet, no
study has investigated the effect of exercise training-induced
changes in VLDL metabolism on IHL content in humans, but
some studies have investigated how exercise training influ-
ences VLDL secretion and clearance. For example, 6 months
of supervised exercise training resulted in a significant decrease
in VLDL–ApoB-100 secretion rate in obese individuals with
type 2 diabetes [81]. The VLDL–ApoB-100 catabolic rate,
representing removal of VLDL particles from the vascular
compartment by complete hydrolysis to IDL or by direct re-
moval via the hepatic VLDL receptor [81], did not change.
Moreover, the VLDL–TAG/ApoB-100 ratio was not altered,
suggesting there was no change in TAG content per VLDL
particle secreted. Since VLDL–ApoB-100 secretion rate de-
creased, plasma VLDL–TAG concentrations decreased.
These findings were confirmed in a 2 month exercise training
experiment with sedentary, non-obese young men [82]. Stable
isotope-labelled 1,1,2,3,3-[2H5]glycerol tracer infusion in the
post-absorptive phase revealed VLDL–TAG concentrations to
be reduced by 28%, due to a 35% reduction in the hepatic
VLDL–TAG secretion rate, whereas no differences in
VLDL–TAG clearance could be observed. Thus, with exercise
training, there seems to be a decrease in hepatic VLDL–TAG
secretion. Although this indicates beneficial adaptation in liver
metabolism, it cannot explain why exercise training lowers IHL
content, since a lower VLDL–TAG secretion would theoreti-
cally lead to greater intrahepatic fat storage. Therefore, the re-
duced VLDL–TAG secretion rate is most likely a consequence
of the reduced IHL content upon exercise training.
Hepatic mitochondrial metabolism The effect of exercise
training on hepatic mitochondrial function has not yet been
investigated in humans. In rodents, several indices of hepatic
mitochondrial content and function were assessed in OLETF
rats after a voluntary wheel running [77, 79] or an exercise
training programme [78]. In these OLETF rats, exercise train-
ing reduced [77, 78] or prevented [79] hepatic fat storage
concomitant with a decrease in key intermediates in hepatic
fatty acid synthesis. Next to the effect on hepatic steatosis and
DNL, these exercised OLETF rats exhibited increased com-
plete palmitate oxidation to CO2 [77–79]. Moreover, hepatic
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citrate synthase (CS) activity [78, 79], β-hydroxyacyl-CoA
dehydrogenase (β-HAD) activity [78, 79] and cytochrome c
(Cyt c) protein content [77] were significantly upregulated.
High CS and β-HAD activity indicates increased aerobic ca-
pacity and mitochondrial density, whereas elevated Cyt c pro-
tein content suggests enhanced final steps of oxidative phos-
phorylation. How exercise training might improve hepatic mi-
tochondrial function is still unclear but the mechanism might
involve enhanced mitochondrial biogenesis. A study in mice
showed that hepatic Cyt c and cytochrome oxidase complex I
protein content increased upon exercise training in wild-type
mice [83] but the increase was absent in mice deficient in
peroxisome proliferator-activated receptor γ coactivator 1-α
(PGC-1α) [83]. This suggests that PGC-1α is required for the
exercise training-induced adaptations of mitochondrial oxida-
tive proteins in mouse liver. Using phosphorus magnetic res-
onance spectroscopy to measure hepatic mitochondrial func-
tion in relation to changes in IHL content with exercise train-
ing should be performed to see whether the observations made
in rodents also hold true for humans.
Effects of acute exercise on IHL content
Liver fat metabolism An alternative way to explain the ef-
fects of exercise training on IHL content is by considering the
accumulating effects of single acute bouts of exercise.
However, hepatic fat content is not decreased after acute ex-
ercise; in fact, some studies report that acute exercise results in
a slightly increased fat content [84, 85].
It has been shown that post-exercise splanchnic NEFA up-
take in individuals with type 2 diabetes increases by 25% on
average compared with the pre-exercise state [86]. Using sta-
ble isotope techniques it was calculated that approximately
50% of whole-body re-esterification immediately after physi-
cal exercise (1 h at 60% of V
:
O2peak ) occurs in the splanchnic
area [87]. This data indicates that splanchnic (i.e. hepatic)
NEFA re-esterification might be an important factor immedi-
ately after exercise. So, while long-term exercise training re-
sults in lower NEFA levels and decreased IHL content, NEFA
are increased after acute exercise and hepatic TAG content
tends to increase after acute exercise in the fasted state.
DNLWhile it is not yet known how DNL is affected by long-
term exercise training in humans, there are some data on the
acute effect of exercise. Rabøl and colleagues [88] investigat-
ed the effect of a single exercise bout on DNL in insulin-
resistant individuals performing 45 min of exercise or rest.
After IHL content was determined, study participants were
given a high-carbohydrate liquid meal (55 energy% carbohy-
drates) and deuterium-labelled water to measure DNL rates.
They showed that DNL activity was significantly reduced in
the exercise condition and this prevented the increase in IHL
content that occurred during the resting condition, indicating
that exercise positively influenced the rate of DNL after a
subsequent meal. In this study, plasma glucose and plasma
insulin levels were the same in the exercise and resting condi-
tions but acute exercise induced a threefold increase in post-
prandial muscle glycogen synthesis. Thus, the single exercise
bout redirected plasma glucose towards storage in skeletal
muscle instead of liver, most likely via non-insulin-
stimulated skeletal muscle glucose uptake by translocation of
GLUT-4 [89, 90]. Therefore, eventually, the accumulated low-
ering effect of single bouts of exercise on DNL, by redirecting
plasma glucose towards skeletal muscle, might contribute to
the exercise training-induced decreases in IHL content.
Hepatic VLDL metabolism Exercise training reduces
VLDL–TAG secretion and during acute exercise there may
be a similar response. Two studies using VLDL–TAG and
palmitate tracers measured VLDL secretion directly during,
and after 90 min of, aerobic exercise at 50% of the V
:
O2max
[91, 92]. These studies showed that in both healthy lean indi-
viduals and in overweight untrained men hepatic VLDL–TAG
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secretion and clearance were reduced during exercise and in
the early recovery phase. Furthermore, because VLDL–TAG
secretion and clearance were both reduced to a similar extent,
plasma VLDL–TAG concentrations were not changed.
Therefore it can be suggested that, in the early recovery phase,
changes in VLDL–TAG secretion and/or clearance do not
contribute to decreases in plasma TAG levels.
Plasma TAG levels remain relatively low for 24 h after an
acute exercise bout [93], after which they return to baseline
values. Although changes in VLDL–TAG metabolism do not
contribute to the decrease in plasma TAG in the early recovery
phase, it might be that they contribute to the sustained lower
plasma TAG the day after a single exercise bout [93]. It has
been shown that moderate-intensity exercise bouts lasting at
least 2 h reduce plasma TAG concentrations by approximately
30% [94–96], whereas shorter bouts of similar exercise have
no effect on plasma TAG concentrations [97, 98].
Consistently, it was found that 2 h of evening exercise (60%
of the V
:
O2peak) did increase fasted VLDL-TAG clearance rate
by approximately 40% on the following day, without affecting
VLDL–TAG secretion in healthy, lean, young men [93]. In
women, a comparable exercise protocol decreased VLDL–
TAG secretion rate on the following day by approximately
22%, concomitant with increased VLDL–TAG clearance
[99]. Thus, performing acute exercise for 2 h in the evening
induces changes in VLDL–TAGmetabolism on the following
day and these changes positively affect TAG concentrations,
mainly by causing increased clearance of VLDL–TAG from
the plasma and only marginally involving changes in hepatic
VLDL–TAG secretion.
Conclusions
NAFL develops due to higher hepatic fat availability and syn-
thesis, which is not fully compensated by increased secretion and
oxidation of hepatic TAG. Weight loss plus exercise training is
very effective in decreasing IHL content. When body weight is
kept constant, exercise training by itself also brings about a dis-
tinct, but more modest, decrease in IHL content. Exercise train-
ing lowers IHL content most likely via a reduction in hepatic fat
availability and synthesis, and an increase in hepatic TAG oxi-
dation. A single bout of exercise seems to increase rather than
decrease IHL content and elevated plasma NEFA during exer-
cise and in the post-exercise period might be the main determi-
nant. Clearly, further research needs to be performed to better
understand the underlying pathways and systems involved in the
beneficial effects of physical activity on hepatic metabolism and
crosstalk with whole-body metabolism.
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